Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

No Endocrine Therapy in Small HR⁺/HER2- Low Risk Luminal A Early Breast Cancer, a Single-arm De-escalation Trial

NCT07661927 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT07661927
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07661927 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
No Endocrine Therapy in Small HR⁺/HER2- Low Risk Luminal A Early Breast Cancer, a Single-arm De-escalation Trial
Lead sponsor
UNICANCER
Phase
Phase 2
Overall status
Recruiting
Start date
July 6, 2026
Completion date
July 6, 2033
Enrollment
700 (estimated)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer (early breast cancer)